Aggregated
43% success rate- Bullish
- 0
- Hold
- 0
- Bearish
- 0
Roth MKM
A Roth MKM analyst with 8 tracked ratings across 8 distinct tickers has a 42.9% success rate on the captured sample, covering two sources with ratings issued as of November 29, 2023.
Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.
| Ticker | Date | Rating | Price target | Source |
|---|---|---|---|---|
| FBIO | 2023-11-29 | buy | $15.00 | Aggregated |
| FBIOFORTRESS BIOTECH INC | 2023-11-29 | unknown | $15.00 | Aggregated |
| RVPHREVIVA PHARMACEUTICALS HOLDINGS INC. | 2023-10-30 | unknown | $12.00 | Aggregated |
| CSBR | 2023-09-22 | buy | $7.50 | Aggregated |
| CSBRCHAMPIONS ONCOLOGY INC | 2023-09-22 | unknown | $7.50 | Aggregated |
| DCTH | 2023-08-16 | buy | $13.00 | Aggregated |
| DCTHDELCATH SYSTEMS INC | 2023-08-16 | unknown | $13.00 | Aggregated |
| VKTXVIKING THERAPEUTICS INC | 2023-05-03 | unknown | $24.00 | Aggregated |
| Ticker | Ratings | Last rating | Sources |
|---|---|---|---|
| FBIO | 1 | 2023-11-29 | Aggregated |
| FBIOFORTRESS BIOTECH INC | 1 | 2023-11-29 | Aggregated |
| RVPHREVIVA PHARMACEUTICALS HOLDINGS INC. | 1 | 2023-10-30 | Aggregated |
| CSBR | 1 | 2023-09-22 | Aggregated |
| CSBRCHAMPIONS ONCOLOGY INC | 1 | 2023-09-22 | Aggregated |
| DCTH | 1 | 2023-08-16 | Aggregated |
| DCTHDELCATH SYSTEMS INC | 1 | 2023-08-16 | Aggregated |
| VKTXVIKING THERAPEUTICS INC | 1 | 2023-05-03 | Aggregated |